1. Home
  2. ECOR vs CULP Comparison

ECOR vs CULP Comparison

Compare ECOR & CULP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo electroCore Inc.

ECOR

electroCore Inc.

HOLD

Current Price

$6.10

Market Cap

50.0M

Sector

Health Care

ML Signal

HOLD

Logo Culp Inc.

CULP

Culp Inc.

HOLD

Current Price

$2.89

Market Cap

43.8M

ML Signal

HOLD

Company Overview

Basic Information
Metric
ECOR
CULP
Founded
2005
1972
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Textiles
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
50.0M
43.8M
IPO Year
2018
1994

Fundamental Metrics

Financial Performance
Metric
ECOR
CULP
Price
$6.10
$2.89
Analyst Decision
Strong Buy
Analyst Count
2
0
Target Price
$22.00
N/A
AVG Volume (30 Days)
46.9K
24.6K
Earning Date
01-01-0001
06-08-2026
Dividend Yield
N/A
N/A
EPS Growth
53.51
N/A
EPS
N/A
N/A
Revenue
$25,182,000.00
$213,237,000.00
Revenue This Year
$28.92
N/A
Revenue Next Year
$32.50
$6.83
P/E Ratio
N/A
N/A
Revenue Growth
57.09
N/A
52 Week Low
$4.16
$2.73
52 Week High
$9.22
$5.64

Technical Indicators

Market Signals
Indicator
ECOR
CULP
Relative Strength Index (RSI) 42.70 28.89
Support Level $4.64 N/A
Resistance Level $8.02 $3.60
Average True Range (ATR) 0.71 0.19
MACD -0.16 -0.04
Stochastic Oscillator 5.42 14.27

Price Performance

Historical Comparison
ECOR
CULP

About ECOR electroCore Inc.

electroCore Inc is a commercial stage bioelectronic medicine company with a platform for non-invasive vagus nerve stimulation therapy initially focused on neurology. The company's product gammaCore is Food and Drug Administration cleared in the United States for adjunctive use for the preventive treatment of cluster headache in adult patients, the acute treatment of pain associated with episodic cluster headache in adult patients, the acute treatment of pain associated with migraine headache in adult patients, and the prevention of migraine in adult patients, The use of gammaCore by adolescent patients and Treatment of hemicrania continua and paroxysmal hemicrania in adult patients.

About CULP Culp Inc.

Culp Inc manufactures, markets mattress fabrics for bedding and upholstery fabrics for residential, commercial, and hospitality furnishings. The company has two operating segments: Mattress fabrics, which generate maximum revenue, and Upholstery fabrics. The mattress fabrics segment manufactures, sources, and sells fabrics and mattress covers to bedding manufacturers. The upholstery fabrics segment develops, sources, manufactures, and sells fabrics to residential, commercial, and hospitality furniture manufacturers. Geographically, it derives key revenue from the United States of America.

Share on Social Networks: